| Literature DB >> 34831659 |
Meng Cao1,2, Yucheng Tang1,2, Shu Li1, Yu Zou3.
Abstract
Background: The purpose of this review was to compare the effectiveness of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on cardiometabolic risk factors of obese children and adolescents.Entities:
Keywords: adolescents; cardiometabolic; children; high-intensity interval training; obesity
Mesh:
Year: 2021 PMID: 34831659 PMCID: PMC8623248 DOI: 10.3390/ijerph182211905
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram of the study selection. MICT: moderate-intensity continuous training.
Descriptive characteristics of the included studies of overweight and obese children and adolescents.
| Study | Subjects’ Characteristic | Training Information | Outcomes | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Status | Age |
| Gender | Group | Training Modality, Setting and Protocol | Time (Min/Session) | Frequency | Duration (Weeks) | ||
| Miguet et al. [ | OW | 13.6 ± 1.5 | 22 | NR | HIIT | Bicycle (lab) 15 × [30 s (90% VO2max): 30 s (50 w)] | 15 | 2 | 16 | ① |
| 13.6 ± 1.5 | 21 | NR | MICT | Bicycle (lab) 45 min (70% VO2max) | 45 | |||||
| Morissey et al. [ | OW | 15.0 ± 1.4 | 16 | 4/12 | HIIT | Mix (lab) 4–6 × [120–150 s (90–95% HRmax): 90 s (55% HRmax)] | 14–24 | 3 | 12 | ①③④⑤ |
| 15.0 ± 1.6 | 13 | 4/9 | MICT | Mix (lab) 40–60 min (65–70% HRmax) | 40–60 | |||||
| Cvetković et al. [ | OW/OB | 11–13 | 11 | 11/0 | HIIT | Run (school) 3 × 5–10 × [10–20 s (100% MAS): 10–20 s (0)]: 3 min (0) | 11–26 | 3 | 12 | ①②③ |
| 11–13 | 10 | 10/0 | MICT | Football (school) 60 min (NR) | 60 | |||||
| Dias et al. [ | OB | 7–16 | 17 | NR | HIIT | Treadmill (lab) 4 × [4 min (85–95% HRmax): 3 min (50–70% HRmax)] | 28 | 3 | 12 | ①②④⑤ |
| 7–16 | 24 | NR | MICT | Treadmill (lab) 44 min (60–70% HRmax) | 44 | |||||
| Lazzer et al. [ | OB | 16.8 ± 0.7 | 10 | 10/0 | HIIT | Treadmill (lab) 6 × [40 s (100% VO2max): 5 min (40% VO2max)] | 34 | 3 | 3 | ①② |
| 16.4 ± 1.1 | 11 | 11/0 | MICT | Treadmill (lab) 45 min × (70% VO2max) | 45 | |||||
| Kargarfard et al. [ | OB | 12.4 ± 1.3 | 10 | 10/0 | HIIT | Treadmill (lab) 8 × [4 min (80–90% HRR): 2 min (40–50% HRR)] | 48 | 3 | 8 | ①②③ |
| 12.4 ± 1.3 | 10 | 10/0 | MICT | Treadmill (lab) 45 min (60–70% HRR) | 45 | |||||
| Murphy et al. [ | OB | 13.7 ± 2.0 | 7 | 2/5 | HIIT | Treadmill (lab) 10 × [1 min (80–90% HRmax): 2 min (60% HRmax)] | 30 | 3 | 4 | ①② |
| 14.3 ± 1.2 | 6 | 5/1 | MICT | Treadmill (lab) 30 min (65% HRmax) | 30 | |||||
| Starkoff et al. [ | OB | 14.9 ± 1.6 | 14 | 5/9 | HIIT | Bicycle (lab) 10 × [2 min (90–95% HRmax): 1 min (55% HRmax)] | 30 | 3 | 6 | ①② |
| 14.5 ± 1.4 | 13 | 5/8 | MICT | Bicycle (lab) 30 min (65–70% HRmax) | 30 | |||||
| Farah et al. [ | OB | 15.4 ± 0.4 | 9 | 5/4 | HIIT | Treadmill (lab) NR × [30 s (120% MAS): 30 s (0)] EE 350 kcal | NR | 3 | 24 | ①②③⑤ |
| 14.8 ± 0.4 | 10 | 5/5 | MICT | Treadmill (lab) NR (80% VT) EE 350 kcal | NR | |||||
| Boer et al. [ | OB | 18.0 ± 3.2 | 17 | 11/6 | HIIT | Bicycle (lab) 10 × [15 s (100% VT): 45 s (50% VT)] | 10 | 2 | 15 | ①③④⑤ |
| 16.7 ± 3.6 | 15 | 10/5 | MICT | Bicycle (lab) 30 min (NR) | 30 | |||||
| Koubaa et al. [ | OB | 13.0 ± 0.8 | 14 | 14/0 | HIIT | Treadmill (lab) NR × [2 min (80–90% MAS): 1 min (0)] | NA | 3 | 12 | ①②③④ |
| 12.9 ± 0.5 | 15 | 15/0 | MICT | Treadmill (lab) NR (60–70% MAS) | NA | |||||
| Araujo et al. [ | OB | 10.7 ± 0.7 | 15 | 5/10 | HIIT | Bicycle (lab) 3–6 × [1 min (100% MAS): 3 min (50% MAS)] | 12–24 | 3 | 12 | ①③④⑤ |
| 10.4 ± 0.9 | 15 | 4/11 | MICT | Treadmill (lab) 30–60 min (80% HRmax) | 30–60 | |||||
Note: ① body composition markers (BM, BMI, BF%, WC, VAT, FFM, etc.), ② cardiorespiratory fitness (VO2max, includes yo-yo test distance or PACER times), ③ blood pressure (SBP and DBP), ④ lipid profile (TG, TC, HDL-C, LDL-C, etc.) and ⑤ glucose markers (BG, BI, HOMA-IR). Description of HIIT protocol: 2 × 10 × [1 min (90% HRmax):1 min (0)]:3 min (0) means 2 sets in each session, 3 min recovery between sets and perform 10 bouts of 1 min work at 90% HRmax and 1 min rest each set. BM: body mass, BMI: body mass index, BF%: body fat percentage, BG: blood glucose, BI: blood insulin, DBP: diastolic blood pressure, EE: energy expenditure, FFM: fat-free mass, HDL-C: high-density lipoprotein cholesterol, HIIT: high-intensity interval training, HOMA-IR: homeostasis model assessment, HRmax: maximal heart rate, LDL-C: low-density lipoprotein cholesterol, MAP: maximal aerobic power, MAS: maximal aerobic speed, MICT: moderate-intensity continuous training, MS: maximal speed, NA: not available, NR: not reported, OB: obese, OW: overweight, SBP: systolic blood pressure, TC: total cholesterol, TG: triglycerides, VAT: visceral adipose tissue, VT: ventilatory threshold, WC: waist circumference, VO2max: maximal oxygen uptake.
Risk of bias assessment of the included studies.
| Study | Assessment | Score | Risk of Bias | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| Miguet | ● | ● | ● | ○ | ○ | ● | ● | ○ | 5 | Moderate |
| Morissey | ● | ● | ● | ○ | ● | ● | ○ | ● | 6 | Moderate |
| Cvetković | ● | ● | ● | ○ | ● | ● | ○ | ● | 6 | Moderate |
| Dias | ● | ● | ● | ○ | ● | ● | ● | ● | 7 | Low |
| Lazzer | ● | ● | ● | ○ | ● | ● | ○ | ● | 6 | Moderate |
| Kargarfard | ● | ● | ● | ○ | ● | ● | ○ | ● | 6 | Moderate |
| Murphy | ● | ● | ● | ○ | ● | ● | ○ | ○ | 5 | Moderate |
| Starkoff | ● | ● | ● | ○ | ● | ● | ● | ○ | 6 | Moderate |
| Farah | ● | ● | ● | ● | ○ | ○ | ○ | ● | 5 | Moderate |
| Boer | ● | ○ | ○ | ○ | ● | ● | ○ | ○ | 3 | High |
| Koubaa | ● | ● | ○ | ○ | ○ | ● | ○ | ○ | 3 | High |
| Araujo | ● | ● | ● | ○ | ● | ● | ○ | ● | 6 | Moderate |
Note: (1) Qualification criteria were specified, (2) participants were randomly assigned, (3) there was no significant difference in the baseline values of the main outcome(s) between groups, (4) blinding was used by assessors who measured the main outcome(s), (5) used “intention to treat” to analyze the primary outcome(s) data, (6) reported the dropout of main outcome(s) and the dropout of participants was <20%, (7) calculated the sample size and the study had enough power to detect changes in the main outcome(s) and (8) reported the summary results of each group and estimated effect size (difference between groups) and its precision (e.g., 95% confidence interval). ●: clearly described; ○: absent or unclear.
Figure 2Effect of HIIT versus MICT on body mass. SMD: Standardized mean difference, CI: Confidence interval.
Figure 3Effect of HIIT versus MICT on body mass index.
Figure 4Effect of HIIT versus MICT on body fat percentage.
Figure 5Effect of HIIT versus MICT on fat free mass.
Figure 6Effect of HIIT versus MICT on abdominal fat.
Figure 7Effect of HIIT versus MICT on maximal oxygen uptake.
Figure 8Effect of HIIT versus MICT on systolic blood pressure.
Figure 9Effect of HIIT versus MICT on diastolic blood pressure.
Figure 10Effect of HIIT versus MICT on triglycerides.
Figure 11Effect of HIIT versus MICT on total cholesterol.
Figure 12Effect of HIIT versus MICT on high-density lipoprotein cholesterol.
Figure 13Effect of HIIT versus MICT on low-density lipoprotein cholesterol.
Figure 14Effect of HIIT versus MICT on blood glucose.
Figure 15Effect of HIIT versus MICT on blood insulin.
Figure 16Effect of HIIT versus MICT on HOMA-IR.
Subgroup analysis of effects of HIIT vs. MICT on cardiorespiratory fitness.
| Subgroup | Synthesis Studies/Total (%) | SMD (95% CI) | MICT | HIIT | |||
|---|---|---|---|---|---|---|---|
|
| 8/8 (100) | 0.87 (0.39, 1.35) |
| 56.8 | 0.023 | ||
|
| 0.903 | ||||||
| Boys | 4/8 (50) | 0.91 (0.17, 1.65) | 63.6 | 0.041 | |||
| Both | 4/8 (50) | 0.83 (0.10, 1.56) | 61.8 | 0.049 | |||
|
| 0.472 | ||||||
| ≤13 years | 4/8 (50) | 0.69 (0.23, 1.16) | 25.6 | 0.258 | |||
| >13 years | 4/8 (50) | 1.12 (0.15, 2.09) | 73.4 | 0.010 | |||
|
| 0.257 | ||||||
| Running | 6/8 (75) | 1.05 (0.47, 1.64) * | 61.2 | 0.024 | |||
| Cycling | 2/8 (25) | 0.29 (−0.34, 0.92) | 0.0 | 0.370 | |||
|
| 0.525 | ||||||
| ≤8 weeks | 4/8 (50) | 0.68 (−0.04, 1.39) | 57.3 | 0.071 | |||
| >8 weeks | 4/8 (50) | 1.05 (0.34, 1.76) * | 63.1 | 0.043 | |||
|
| 0.473 | ||||||
| <20 min | 2/8 (25) | 1.64 (0.79, 2.49) * | 34.2 | 0.218 | |||
| 20–30 min | 4/8 (50) | 0.47 (0.06, 0.88) * | 0.0 | 0.633 | |||
| >30 min | 2/8 (25) | 1.09 (−0.40, 2.58) | 79.0 | 0.029 | |||
|
| 0.375 | ||||||
| Laboratory | 6/8 (75) | 0.81 (0.34, 1.28) * | 44.0 | 0.112 | |||
| School | 2/8 (25) | 1.16 (−0.78, 3.10) | 86.1 | 0.007 | |||
|
| 0.686 | ||||||
| <1 | 2/8 (25) | 0.98 (−0.81, 2.76) | 82.1 | 0.018 | |||
| =1 | 2/8 (25) | 1.16 (−0.78, 3.10) | 86.1 | 0.007 | |||
| >1 | 4/8 (50) | 0.75 (0.36, 1.14) * | 0.1 | 0.391 | |||
|
| 0.296 | ||||||
| <1 min | 3/8 (38) | 1.38 (0.10, 2.66) * | 79.0 | 0.009 | |||
| 1–4 min | 2/8 (24) | 0.68 (−0.01, 1.37) | 46.4 | 0.155 | |||
| =4 min | 3/8 (38) | 0.62 (0.08, 1.17) * | 0.0 | 0.446 | |||
* means that the improvement of VO2max is significantly different in this subgroup parameter.
Subgroup analysis of effects of HIIT vs. MICT on systolic blood pressure.
| Subgroup | Synthesis Studies/Total (%) | SMD (95% CI) | MICT | HIIT | |||
|---|---|---|---|---|---|---|---|
|
| 7/7 (100) | −0.64 (−1.05, −0.22) |
| 44.9 | 0.092 | ||
|
| 0.770 | ||||||
| Boys | 4/7 (51) | −0.58 (−0.98, −0.18) * | 0.0 | 0.009 | |||
| Both | 3/7 (49) | −0.78 (−1.83, 0.27) | 79.0 | 0.072 | |||
|
| 0.770 | ||||||
| ≤13 years | 4/7 (51) | −0.58 (−0.98, −0.18) * | 0.0 | 0.722 | |||
| >13 years | 3/7 (49) | −0.78 (−1.83, 0.27) | 79.0 | 0.009 | |||
|
| 0.489 | ||||||
| Running | 5/7 (71) | −0.73 (−1.16, −0.31) * | 20.2 | 0.286 | |||
| Cycling | 2/7 (29) | −0.40 (−1.54, 0.75) | 79.5 | 0.027 | |||
|
| 0.876 | ||||||
| ≤8 weeks | 1/7 (14) | −0.74 (−1.65, 0.17) | - | - | |||
| >8 weeks | 6/7 (86) | −0.63 (−1.11, −0.15) * | 53.7 | 0.056 | |||
|
| 0.794 | ||||||
| <20 min | 4/7 (71) | −0.66 (−1.38, 0.07) | 69.7 | 0.019 | |||
| 20–30 min | 1/7 (14) | −0.34 (−1.20, 0.52) | - | - | |||
| >30 min | 2/7 (25) | −0.82 (−1.40, −0.24) * | 44.9 | 0.092 | |||
|
| 0.493 | ||||||
| Laboratory | 5/7 (71) | −0.54 (−0.98, −0.11) * | 36.9 | 0.175 | |||
| School | 2/7 (29) | −0.98 (−2.31, 0.35) | 73.4 | 0.052 | |||
|
| 0.169 | ||||||
| <1 | 2/7 (29) | −0.93 (−1.46, −0.40) * | 0.0 | 0.843 | |||
| =1 | 2/7 (29) | −0.98 (−2.31, 0.35) | 73.4 | 0.052 | |||
| >1 | 3/7 (42) | −0.26 (−0.78, 0.26) | 23.4 | 0.271 | |||
|
| 0.493 | ||||||
| <1 min | 3/7 (43) | −0.96 (−1.65, −0.26) * | 47.5 | 0.149 | |||
| 1–4 min | 3/7 (43) | −0.35 (−0.95, 0.25) | 49.4 | 0.138 | |||
| =4 min | 1/7 (14) | −0.74 (−1.65, 0.17) | - | - | |||
* means that the improvement of VO2max is significantly different in this subgroup parameter.
Effects of HIIT and MICT on body composition, cardiorespiratory fitness, blood pressure and glycolipid metabolism indicators.
| Outcomes | Studies/Total (%) |
| SMD (95% CI) | Favored HIIT | Favored MICT |
|
| |
|---|---|---|---|---|---|---|---|---|
|
| 12/12 (100) | 325 |
| |||||
|
| ||||||||
| BM | 11/12 (92) | 313 | −0.10 (−0.61, 0.41) | 78.4 | 46.3 | 0.001 | ||
| BMI | 12/12 (100) | 325 | 0.03 (−0.75, 0.80) | 89.8 | 107.3 | 0.001 | ||
| BF% | 10/12 (83) | 277 | −0.23 (−0.73, 0.28) | 74.5 | 35.3 | 0.001 | ||
| AF | 6/12 (50) | 178 | −0.21 (−1.19, 0.76) | 88.3 | 42.8 | 0.001 | ||
| FFM | 6/12 (50) | 184 | 0.15 (−0.16, 0.45) | 3.6 | 5.2 | 0.394 | ||
|
| ||||||||
| VO2max | 8/12 (67) | 191 | 0.87 (0.39, 1.35) * | 56.8 | 16.2 | 0.023 | ||
|
| ||||||||
| SBP | 7/12 (58) | 180 | −0.64 (−1.05, −0.22) * | 44.9 | 10.9 | 0.092 | ||
| DBP | 7/12 (58) | 180 | −0.13 (−0.88, 0.61) | 82.1 | 33.6 | 0.001 | ||
|
| ||||||||
| TG | 5/12 (42) | 161 | −0.20 (−0.59, 0.19) | 33.2 | 6.0 | 0.200 | ||
| TC | 5/12 (42) | 161 | −0.11 (−0.94, 0.72) | 83.9 | 24.8 | 0.001 | ||
| HDL-C | 4/12 (33) | 125 | −0.18 (−1.34, 0.99) | 89.5 | 28.5 | 0.001 | ||
| LDL-C | 3/12 (25) | 101 | −0.01 (−1.19, 1.18) | 87.0 | 15.4 | 0.001 | ||
| BG | 4/12 (33) | 125 | −0.02 (−0.37, 0.34) | 0 | 2.9 | 0.406 | ||
| BI | 4/12 (33) | 125 | −0.21 (−0.99, 0.57) | 74.5 | 11.8 | 0.008 | ||
| HOMA-IR | 4/12 (33) | 132 | 0.08 (−0.54, 0.70) | 70.1 | 13.4 | 0.010 | ||
Note: VO2max, FFM and HDL-C were positively correlated with health benefits; therefore, the forest plot reflects that the favorable direction of these two indicators was opposite to the labeling direction, that is, HIIT is shown as favorable on the right side of the invalid line. * means that the improvement of VO2max is significantly different in this subgroup parameter.